-
Opioid drugmaker Insys Therapeutics files for bankruptcy
10 Jun 2019 11:12 GMT
(Reuters) - Drugmaker Insys Therapeutics Inc filed for Chapter 11 … Kapoor, the billionaire founder of Insys Therapeutics Inc, leaves the federal courthouse … what became the best-performing initial public offering of that year.
The Justice …
-
INSYS Therapeutics Implements Leadership Changes
15 Apr 2019 12:30 GMT
… 15, 2019 (GLOBE NEWSWIRE) -- INSYS Therapeutics, Inc. (NASDAQ: INSY), a leader … leading up to Patheon’s IPO. Prior to working at Patheon …
-
INSYS Therapeutics Hires First Corporate Communications Leader and New Investor Relations Agency
21 Sep 2017 20:01 GMT
… 2017 (GLOBE NEWSWIRE) -- Insys Therapeutics, Inc. (NASDAQ:INSY) … About INSYS
Insys Therapeutics is a specialty pharmaceutical … measurement, perception studies, IPOs, transaction and crises … , Corporate Communications
INSYS Therapeutics
480-500-3101 …
-
Insys Therapeutics, Inc. Appoints Andrew G. Long as Chief Financial Officer
18 Jul 2017 10:50 GMT
… leading up to Patheon’s IPO. Prior to his role … CFO since the Company’s IPO in 2013, for his … added Motahari. About INSYS
Insys Therapeutics is a specialty pharmaceutical company … , Inc., a subsidiary of Insys Therapeutics, Inc. Forward-Looking Statements …
-
Insys Therapeutics Announces Chief Financial Officer Transition
16 May 2017 10:50 GMT
… , 2017 (GLOBE NEWSWIRE) -- Insys Therapeutics, Inc. (NASDAQ:INSY) … evolution from a pre-IPO startup to a … candidates." About Insys
Insys Therapeutics is a specialty pharmaceutical … Inc., a subsidiary of Insys Therapeutics, Inc. Forward-Looking Statements …
-
Stoke Therapeutics Files Proposed Terms For IPO
11 Jun 2019 17:23 GMT
… Therapeutics GW Pharmaceuticals (GHPH) INSYS Therapeutics (INSY) OPKO Health (OPK … . (Unaudited, interim) IPO Details STOK intends to … signal for IPO investors. Assuming a successful IPO, the … IPO research, news, and industry analysis for all U.S. IPOs …
-
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials, Earnings And IPOs
23 Mar 2019 17:01 GMT
… FG-3019 (Duchenne muscular dystrophy)
Insys Therapeutics Inc (NASDAQ: INSY) – Phase … (after the market close)
IPO
Genfit, a biopharma company focusing … million shares in an IPO, with an estimated price … the ticker symbol DTIL.
IPO Quiet Period Expiry
Kaleido …